Summary
- Current Price
- As of today, ALGS price is $6.91, down -2.26% on
- Current Price All-Time High
- ALGS price is currently -99.26% below its historical high of $937.75 set on
- Market Cap
- ALGS current market cap is $43M, down -36.58% year-over-year
- Revenue
- ALGS current annual revenue is $2.19M, down -44.59% year-over-year
- Next Earnings
- The next earnings release for ALGS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Aligos Therapeutics, Inc. |
| Ticker | NASDAQ: ALGS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | aligos.com |
| Employees | 70 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $6.91 | ||
| Price, 1D Change | -2.26% | |
| $43M | ||
| - | ||
| - | ||
| 1.34 | ||
| $2.19M | ||
| Revenue, 1Y Change | -44.59% | |
| -$2.45 | ||
| EPS, 1Y Change | +88.31% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:25 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.45 | ||
| EPS Estimate | -$6.58 | N/A |
| EPS Est. Change | -168.76% | N/A |
| $2.19M | ||
| Revenue Estimate | $36.33M | N/A |
| Revenue Est. Change | +1,562.10% | N/A |
| $6.91 | ||
| Price Target | $45.00 | - |
| Price Tgt. Change | +551.23% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$10.36 | -$20.94 | -102.17% | |
| -$7.59 | -$2.45 | +67.74% | |
| -$6.58 | N/A | -168.76% | |
| -$5.05 | N/A | -106.50% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.74M | $3.95M | +5.37% | |
| $2.45M | $2.19M | -10.66% | |
| $36.33M | N/A | +1,562.10% | |
| $5.43M | N/A | +148.17% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -37.52% | ||
| -68.41% | ||
| -36.58% | ||
| +13.36% | ||
| -44.59% | ||
| -84.28% | ||
| +88.31% | ||
| -100.00% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $6.91 | ||
| $7.15 | ||
| $5.86 | ||
| $7.11 | ||
| $6.12 | ||
| $0.45 | ||
| 1.34 | ||
| $0.59 | ||
| 56.88 | ||
| 75.45% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $2.19M | ||
| -$2.45 | ||
| $1.26M | ||
| 57.46% | ||
| -$87.99M | ||
| -4,024.93% | ||
| -$24.19M | ||
| -1,106.72% | ||
| -$87.06M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.10 | ||
| 3.90 | ||
| 3.90 | ||
| - | ||
| 3 | ||
| -11.71 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 1.37 | ||
| 1.35 | ||
| -0.21 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $53.55M | ||
| $77.95M | ||
| $89.58M | ||
| $82.86M | ||
| $36.04M | ||
| $21.23M | ||
| $5.25M | ||
| $3.73M | ||
| $3.98M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $26.38M | ||
| $89.24M | ||
| $930.00K | ||
| $20.72M | ||
| $930.00K | ||
| $0.00 | ||
| $314.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$82.50M | ||
| -$37.83M | ||
| $101.64M | ||
| $437.00K | ||
| -$82.94M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Lake Street | ||
| Cantor Fitzgerald | ||
| WestPark Capital | ||
| HC Wainwright & Co. | → | |
| UBS | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
No data
Screeners with ALGS
FAQ
- What is the ticker symbol for Aligos Therapeutics, Inc.?
- The ticker symbol for Aligos Therapeutics, Inc. is NASDAQ:ALGS
- Does Aligos Therapeutics, Inc. pay dividends?
- No, Aligos Therapeutics, Inc. does not pay dividends
- What sector is Aligos Therapeutics, Inc. in?
- Aligos Therapeutics, Inc. is in the Healthcare sector
- What industry is Aligos Therapeutics, Inc. in?
- Aligos Therapeutics, Inc. is in the Biotechnology industry
- What country is Aligos Therapeutics, Inc. based in?
- Aligos Therapeutics, Inc. is headquartered in United States
- When did Aligos Therapeutics, Inc. go public?
- Aligos Therapeutics, Inc. initial public offering (IPO) was on October 16, 2020
- Is Aligos Therapeutics, Inc. in the S&P 500?
- No, Aligos Therapeutics, Inc. is not included in the S&P 500 index
- Is Aligos Therapeutics, Inc. in the NASDAQ 100?
- No, Aligos Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Aligos Therapeutics, Inc. in the Dow Jones?
- No, Aligos Therapeutics, Inc. is not included in the Dow Jones index
- When was Aligos Therapeutics, Inc. last earnings report?
- Aligos Therapeutics, Inc.'s most recent earnings report was on August 6, 2026
- When does Aligos Therapeutics, Inc. report earnings?
- The next expected earnings date for Aligos Therapeutics, Inc. is November 5, 2026
Data Sources & References
- ALGS Official Website www.aligos.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1799448/000119312526092614/0001193125-26-092614-index.htm
- ALGS Profile on Yahoo Finance finance.yahoo.com/quote/ALGS
- ALGS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/algs
